NCT05381350View on ClinicalTrials.gov

Immunogenicity and Safety of Booster Immunization of COVID-19 Vaccine (Vero Cell), Inactivated (Omicron Variant) in Healthy People Aged 18 Years and Above

PHASE3CompletedINTERVENTIONAL
Enrollment

1,750

Participants

Timeline

Start Date

June 1, 2022

Primary Completion Date

September 26, 2022

Study Completion Date

March 9, 2023

Conditions
COVID-19
Interventions
BIOLOGICAL

COVID-19 Vaccine (Vero cell), Inactivated (Omicron variant)

The COVID-19 Vaccine (Vero cell), Inactivated (Omicron variant)was manufactured by Sinovac Research\& Development Co., Ltd.1200SOU inactivated SARS-CoV-2 Omicron strain in 0.5ml of aluminium hydroxide solution per injection.

BIOLOGICAL

COVID-19 Vaccine (Vero cell), Inactivated (CZ strain)

The COVID-19 vaccine,inactivated was manufactured by Sinovac Research\& Development Co., Ltd.600SU inactivated SARS-CoV-2 CZ strain virus in 0.5 mL of aluminium hydroxide solution per injection.

Trial Locations (1)

223300

Huaiyin Center for Disease Control and Prevention, Huai'an

All Listed Sponsors
lead

Sinovac Research and Development Co., Ltd.

INDUSTRY